Chemotherapy of Bladder Carcinoma with Cyclophosphamide and Adriamycin
- 1 December 1975
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 114 (6) , 884-887
- https://doi.org/10.1016/s0022-5347(17)67165-9
Abstract
We assigned 49 patients with transitional cell carcinoma of the bladder to 1 of 3 groups: 21 patients (group 1) received cyclophosphamide alone, 10 patients (group 2) received adriamycin alone and 18 patients (group 3) received cyclophosphamide and adriamycin. The objective responses were 52.3 per cent in group 1, 10 per cent in group 2 and 50 per cent in group 3. These results suggest a significant activity of the drugs (especially in groups 1 and 3) tested in bladder cancer.Keywords
This publication has 8 references indexed in Scilit:
- Methotrexate Treatment for Advanced Bladder CancerBritish Journal of Urology, 1974
- The Radiation AttackPublished by American Medical Association (AMA) ,1969
- Meaningful clinical classification of therapeutic responses to anticancer drugsClinical Pharmacology & Therapeutics, 1961
- Chemotherapy of human solid tumors with 5-fluorouracilCancer, 1960
- The Relation of the Preoperative Estimate to the Pathologic Demonstration of the Extent of Vesical NeoplasmsJournal of Urology, 1952
- Carcinoma of the Bladder: Influence of Depth of Infiltration on the 5-year Results Following Complete Extirpation of the Primary GrowthJournal of Urology, 1952
- Infiltrating Carcinoma of the Bladder: Relation of Depth of Penetration of the Bladder Wall to Incidence of Local Extension and MetastasesJournal of Urology, 1946